1. Home
  2. TKNO vs MTLS Comparison

TKNO vs MTLS Comparison

Compare TKNO & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • MTLS
  • Stock Information
  • Founded
  • TKNO 1996
  • MTLS 1990
  • Country
  • TKNO United States
  • MTLS Belgium
  • Employees
  • TKNO N/A
  • MTLS N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • MTLS Computer Software: Prepackaged Software
  • Sector
  • TKNO Health Care
  • MTLS Technology
  • Exchange
  • TKNO Nasdaq
  • MTLS Nasdaq
  • Market Cap
  • TKNO 256.9M
  • MTLS 349.7M
  • IPO Year
  • TKNO 2021
  • MTLS 2014
  • Fundamental
  • Price
  • TKNO $4.35
  • MTLS $5.13
  • Analyst Decision
  • TKNO
  • MTLS
  • Analyst Count
  • TKNO 0
  • MTLS 0
  • Target Price
  • TKNO N/A
  • MTLS N/A
  • AVG Volume (30 Days)
  • TKNO 224.0K
  • MTLS 127.2K
  • Earning Date
  • TKNO 08-07-2025
  • MTLS 10-23-2025
  • Dividend Yield
  • TKNO N/A
  • MTLS N/A
  • EPS Growth
  • TKNO N/A
  • MTLS N/A
  • EPS
  • TKNO N/A
  • MTLS 0.11
  • Revenue
  • TKNO $38,923,000.00
  • MTLS $311,850,851.00
  • Revenue This Year
  • TKNO $9.52
  • MTLS $2.98
  • Revenue Next Year
  • TKNO $15.20
  • MTLS $7.09
  • P/E Ratio
  • TKNO N/A
  • MTLS $48.31
  • Revenue Growth
  • TKNO 11.40
  • MTLS 2.98
  • 52 Week Low
  • TKNO $4.00
  • MTLS $3.93
  • 52 Week High
  • TKNO $10.37
  • MTLS $9.69
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 43.35
  • MTLS 47.90
  • Support Level
  • TKNO $4.22
  • MTLS $5.01
  • Resistance Level
  • TKNO $4.94
  • MTLS $5.32
  • Average True Range (ATR)
  • TKNO 0.29
  • MTLS 0.18
  • MACD
  • TKNO -0.00
  • MTLS 0.02
  • Stochastic Oscillator
  • TKNO 16.75
  • MTLS 52.08

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About MTLS Materialise NV

Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.

Share on Social Networks: